Drug of choice for Palliative treatment pancreatic Carcinoma
**Core Concept**
Pancreatic carcinoma often involves the release of various growth factors, leading to uncontrolled cell proliferation. Palliative treatment aims to alleviate symptoms and improve quality of life in patients with advanced disease.
**Why the Correct Answer is Right**
The drug of choice for palliative treatment of pancreatic carcinoma involves the use of **Gemcitabine**, a nucleoside analog that inhibits DNA synthesis and induces apoptosis in cancer cells. Gemcitabine is a first-line treatment for advanced pancreatic cancer due to its ability to reduce tumor size and alleviate symptoms.
**Why Each Wrong Option is Incorrect**
* **Option A:** This is incorrect as it does not represent a standard treatment for pancreatic carcinoma. Other drugs like 5-fluorouracil (5-FU) may be used in combination with gemcitabine, but it is not the primary choice.
* **Option B:** This is incorrect as it is not a commonly used medication for pancreatic carcinoma. Other treatments like radiation therapy may be used in conjunction with chemotherapy, but it is not a standalone treatment.
* **Option C:** This is incorrect as it is not a standard treatment for pancreatic carcinoma. Other medications like irinotecan may be used in combination with gemcitabine, but it is not the primary choice.
**Clinical Pearl / High-Yield Fact**
Gemcitabine is often used in combination with other medications like **leucovorin** and **5-fluorouracil (5-FU)** to enhance its effectiveness in treating pancreatic carcinoma.
**Correct Answer:** C. Gemcitabine